Skip to content

A retrospective study on the survival status and causes of death of patients with bladder cancer after different treatments

A retrospective study on the survival status and causes of death of patients with bladder cancer after different treatments

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116877
Enrollment
Unknown
Registered
2026-01-15
Start date
2026-01-15
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carcinoma of urinary bladder

Interventions

Transurethral resection of bladder tumor (TURBT) group:None
Bladder partial resection (BPR) group:None
Bladder radical resection (BRR) group:None
Bladder tumor palliative treatment (BTPT) group:None
Bladder tumor symptomatic treatment (BTST) group:None
Bladder tumor radiotherapy and chemotherapy (BTRC) group:None
Traditional Chinese medicine treatment for bladder tumors (TCMT) group:None
Bladder tumor non-treatment (BTNT) group:None

Sponsors

Department of Urology, Affiliated Hospital of Zunyi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 93 Years

Inclusion criteria

Inclusion criteria: (1) All patients with bladder cancer; (2) Time frame: Patients who were diagnosed with bladder cancer through pathological examination and received treatment at our hospital from January 1, 2000 to December 31, 2025; (3) Data completeness: The patients included in the study must have comprehensive and systematic clinical records, detailed pathological data, clear information on the pathological type, grade, stage, etc. of the tumor, as well as complete follow-up data, documenting the patient's condition changes, survival status, recurrence and metastasis after treatment.

Exclusion criteria

Exclusion criteria: (1)Inconsistent disease type: Patients whose discharge diagnosis was confirmed as not bladder cancer after examination; (2)Data deficiency: There is a lack of key information in the clinical records, such as the absence of necessary auxiliary examination results, insufficient diagnostic basis, and unclear treatment plans, which makes it impossible to accurately assess the patient's condition and treatment outcome; (3)Patients with incomplete clinical data; (4)Patients who refused to provide information about their condition during follow-up and whose cause of death could not be determined; (5)Secondary bladder cancer.

Design outcomes

Primary

MeasureTime frame
Gender(1 = Male, 2 = Female);Age (Year);TNM staging;Tumor pathological classification (1 = urothelial carcinoma; 2 = squamous cell carcinoma; 3 = adenocarcinoma; 4 = rhabdomyosarcoma; 5 = pheochromocytoma; 6 = mixed tumor);Tumor status at the initial diagnosis (1 = NMIBC (Tis/Ta/T1); 2 = MICB with local progression without lymph node metastasis; 3 = MICB with local progression and lymph node metastasis; 4 = distant metastasis);T(1=Tis/Ta/T1; 2=T2a; 3=T2b; 4=T3a; 5=T3b; 6=T4a;7=T4b);lymphatic metastasis(0=No;1=Yes);Distant metastasis(0=No;1=Yes);Number of tumors (1 = single; 2 = multiple);Postoperative tumor recurrence (0 = no; 1 = recurrence);Tumor pathological grading (grades 1, 2, and 3);Postoperative tumor metastasis deterioration (0 = no; 1 = yes);Treatment methods (1 = TURBT, 2 = Radical Cystectomy, 3 = Palliative Treatment, 4 = Passive Treatment, 5 = Partial Cystectomy, 6 = Nephrostomy, 7 = Internal Iliac Artery Catheter Chemotherapy, 8 = Care Treatment, 9 = Bladder Puncture Fistulation, 10 = Non-tumor Symptomatic Treatment, 11 = Chemoradiotherapy);Comorbidities include hypertension (0 = no; 1 = yes);Comorbidities include diabetes (0 = no; 1 = yes);Comorbidities include coronary heart disease (0 = no; 1 = yes);Comorbidities include COPD (0 = no; 1 = yes);Associated with the disease was cerebral hemorrhage (0 = no; 1 = yes);Associated with the disease was cerebral infarction (0 = no; 1 = yes);Associated with the disease was the infection with the novel coronavirus (0 = no; 1 = yes);Associated diseases include pulmonary infection (0 = no; 1 = yes);Associated diseases include urinary tract infection (0 = no; 1 = yes);Classification of causes of death (0 = survived; 1 = death related to tumor; 2 = death unrelated to tumor);Death diseases (0 = survival, 1 = hypertension, 2 = diabetes, 3 = coronary heart disease, 4 = COPD, 5 = cerebral hemorrhage, 6 = cerebral infarction, 7 = COVID-19 infection, 8 = traffic accident accident, 9 = medication, suicide by jumping, 10 =

Countries

China

Contacts

Public ContactChen Zongping

Affiliated hospital of Zunyi Medical University

2404259310@qq.com+86 135 0851 2561

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026